138 related articles for article (PubMed ID: 30502381)
1. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
2. Acute and Chronic Effects of Oral Erdosteine on Ciliary Beat Frequency, Cough Sensitivity and Airway Reactivity.
Pappová L; Kazimierová I; Jošková M; Šutovská M; Fraňová S
Adv Exp Med Biol; 2018; 1023():1-10. PubMed ID: 28730380
[TBL] [Abstract][Full Text] [Related]
3. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
4. Mucolytic and antitussive effects of erdosteine.
Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilatory, antitussive and anti-inflammatory effect of morin in the setting of experimentally induced allergic asthma.
Franova S; Kazimierova I; Pappova L; Joskova M; Plank L; Sutovska M
J Pharm Pharmacol; 2016 Aug; 68(8):1064-72. PubMed ID: 27283356
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
7. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy with Budesonide and Salmeterol in Experimental Allergic Inflammation.
Pappová L; Jošková M; Kazimierová I; Šutovská M; Fraňová S
Adv Exp Med Biol; 2016; 935():25-34. PubMed ID: 27329088
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
Hayashi K; Hosoe H; Kaise T; Ohmori K
J Pharm Pharmacol; 2000 Nov; 52(11):1411-6. PubMed ID: 11186250
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic evaluation of dihydroxyflavone derivate chrysin in a guinea pig model of allergic asthma.
Franova S; Molitorisova M; Kazimierova I; Joskova M; Forsberg CIN; Novakova E; Sutovska M
J Pharm Pharmacol; 2021 Mar; 73(2):233-240. PubMed ID: 33793800
[TBL] [Abstract][Full Text] [Related]
11. The anti-asthmatic potential of flavonol kaempferol in an experimental model of allergic airway inflammation.
Molitorisova M; Sutovska M; Kazimierova I; Barborikova J; Joskova M; Novakova E; Franova S
Eur J Pharmacol; 2021 Jan; 891():173698. PubMed ID: 33129789
[TBL] [Abstract][Full Text] [Related]
12. Echinacea complex--chemical view and anti-asthmatic profile.
Šutovská M; Capek P; Kazimierová I; Pappová L; Jošková M; Matulová M; Fraňová S; Pawlaczyk I; Gancarz R
J Ethnopharmacol; 2015 Dec; 175():163-71. PubMed ID: 26364938
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic evaluation of RP3128, a novel and potent CRAC channel inhibitor in guinea pig models of allergic asthma.
Sutovska M; Kocmalova M; Franova S; Vakkalanka S; Viswanadha S
Eur J Pharmacol; 2016 Feb; 772():62-70. PubMed ID: 26724844
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter.
Cao L; Ping F; Zhang F; Gao H; Li P; Ning X; Cui G; Ma Z; Jiang X; Li S; Han S
Med Sci Monit; 2021 Dec; 27():e930909. PubMed ID: 34873140
[TBL] [Abstract][Full Text] [Related]
15. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
16. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
17. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
18. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
20. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]